Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline catalysts.

We all have a concept of reality. We know what is “fact” and what isn’t. However, the truth of the matter is that the definition of “real” is a mere construct of the brain. If that didn’t blow your ...

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet.

Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence ...

Past studies show that SuperAgers may experience slower brain atrophy, lower brain volume loss, and reduced neuroinflammation. Now a new study published in the journal Nature has found that SuperAgers ...

Cancer remains one of the world’s most serious health threats, especially when it spreads beyond its original site. That ...

The Time You Apply Your Skincare Is Important As What You Use. Welcome To The Era Of Circadian Skincare Understanding your ...

And that was also presented at ASH 2025 and also a very, very strong data set. I should mention that BI-1808 that was monotherapy, single-agent therapy. Then, we also started our Phase IIa trial ...

A new study sheds light on the behavior of yeast cells in the gut, paving the way for new lines of yeast that more ...

This study reports an important and novel finding that TENT5A, an enzyme involved in fine-tuning poly(A) tail length on selected mRNAs, is required for proper enamel mineralization in mice. The ...

In a recent study, researchers manipulated cellular proteins that control genes in aged mice. Experimental results showed their livers were rejuvenated to younger states. This work shows promise as a ...

Jan 16 (Reuters) - Danish drugmaker Genmab (GMAB.CO), opens new tab and its U.S. partner AbbVie (ABBV.N), opens new tab said on Friday that their drug for a type of blood cancer failed to improve the ...